Lenvima and Blood test abnormal - a phase IV clinical study of FDA data

Summary:

Blood test abnormal is reported as a side effect among people who take Lenvima (lenvatinib mesylate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Keytruda, and have Endometrial cancer.

The phase IV clinical study analyzes which people have Blood test abnormal when taking Lenvima. It is created by eHealthMe based on reports of 21,107 people who have side effects when taking Lenvima from the FDA, and is updated regularly.

What is Lenvima?

Lenvima has active ingredients of lenvatinib mesylate. eHealthMe is studying from 21,113 Lenvima users. Check the latest studies of Lenvima.

What is Blood test abnormal?

Blood test abnormal is found to be associated with 837 drugs and 722 conditions by eHealthMe. Check the latest studies of Blood test abnormal.

On Jul, 26, 2026

21,107 people reported to have side effects when taking Lenvima.
Among them, 29 people (0.14%) have Blood test abnormal.

Could Lenvima cause Blood test abnormal?

Among these 29 people:

How long have people been on Lenvima when they have Blood test abnormal? *

What is the gender of people who have Blood test abnormal when taking Lenvima? *

female: 48.28 %
male: 51.72 %

What is the age of people who have Blood test abnormal when taking Lenvima? *

What are other drugs people take besides Lenvima? *

What are other side effects people have besides Blood test abnormal? *

Fatigue (feeling of tiredness): 20 people, 68.97%
High Blood Pressure: 18 people, 62.07%
Diarrhea: 14 people, 48.28%
Nausea (feeling of having an urge to vomit): 13 people, 44.83%
Weight Decreased: 10 people, 34.48%
Feeling Cold: 10 people, 34.48%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 10 people, 34.48%
Pain: 9 people, 31.03%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 31.03%
Nausea And Vomiting: 9 people, 31.03%

What are the existing conditions these people have? *

Endometrial Cancer: 10 people, 34.48%
Thyroid Cancer: 8 people, 27.59%
Renal Cell Carcinoma (a kidney cancer): 4 people, 13.79%
Neuroendocrine Tumor: 4 people, 13.79%
Enlarged Prostate: 2 people, 6.90%
Diarrhea: 2 people, 6.90%
Thyroid Neoplasm (tumour of thyroid): 1 person, 3.45%
Stress And Anxiety: 1 person, 3.45%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 3.45%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Lenvima and have Blood test abnormal?

- Check whether Blood test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lenvima:

Lenvima (21,113 reports)

Browse all side effects of Lenvima:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood test abnormal:

Blood test abnormal (837 drugs)

Browse all the conditions that are associated with Blood test abnormal:

Blood test abnormal (722 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenvatinib mesylate (the active ingredients of Lenvima) and Lenvima (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.